METHODS OF TREATING A CARDIOVASCULAR ISCHEMIC EVENT

    公开(公告)号:US20240139290A1

    公开(公告)日:2024-05-02

    申请号:US18405807

    申请日:2024-01-05

    IPC分类号: A61K38/29 A61P9/10

    CPC分类号: A61K38/29 A61P9/10

    摘要: Disclosed herein is a method of treating cardiomyocyte reperfusion injury associated with an ischemic myocardial event. The method includes administering to a subject in need thereof an effective amount of a abaloparatide to a subject in need thereof prior to performing reperfusion, concurrent with performing reperfusion, or both. Further provided is a method of treating cardiomyocyte reperfusion injury associated with cardiac transplant. The method includes contacting a donor heart with an effective amount of abaloparatide.

    Methods for detecting neutralizing antibodies to parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) analog

    公开(公告)号:US11680942B2

    公开(公告)日:2023-06-20

    申请号:US17571312

    申请日:2022-01-07

    发明人: Heidi K. Chandler

    IPC分类号: G01N33/50

    CPC分类号: G01N33/5032 G01N2333/635

    摘要: The present disclosure is directed to methods (e.g., in vitro methods) for detecting the presence of neutralizing antibodies to PTH or PTHrP analog in a sample. The in vitro method comprises the steps of obtaining a sample from a subject; contacting the sample with a cell; measuring cyclic adenosine monophosphate (cAMP) levels; and detecting the presence of neutralizing antibodies when cAMP levels are reduced relative to a negative control sample without neutralizing antibodies. An in vitro method of detecting the presence of neutralizing antibodies in a sample from a subject treated with Abaloparatide, is also provided. Further provided herein is a kit for carrying out the methods described herein comprising components required to carry out the obtaining, contacting, measuring and detecting steps and instructions for use.

    METHODS FOR DETECTING NEUTRALIZING ANTIBODIES TO PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHRP) ANALOG

    公开(公告)号:US20210389300A1

    公开(公告)日:2021-12-16

    申请号:US17369163

    申请日:2021-07-07

    发明人: Heidi K. Chandler

    IPC分类号: G01N33/50

    摘要: The present disclosure is directed to methods (e.g., in vitro methods) for detecting the presence of neutralizing antibodies to PTH or PTHrP analog in a sample. The in vitro method comprises the steps of obtaining a sample from a subject; contacting the sample with a cell; measuring cyclic adenosine monophosphate (cAMP) levels; and detecting the presence of neutralizing antibodies when cAMP levels are reduced relative to a negative control sample without neutralizing antibodies. An in vitro method of detecting the presence of neutralizing antibodies in a sample from a subject treated with Abaloparatide, is also provided. Further provided herein is a kit for carrying out the methods described herein comprising components required to carry out the obtaining, contacting, measuring and detecting steps and instructions for use.

    USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK

    公开(公告)号:US20200061160A1

    公开(公告)日:2020-02-27

    申请号:US16566499

    申请日:2019-09-10

    发明人: Gary Hattersley

    IPC分类号: A61K38/29 A61K45/06 A61K9/00

    摘要: Disclosed herein are PTHrP or analogues thereof, such as abaloparatide, for preventing or reducing bone fractures in subjects in need thereof, as well as methods of using PTHrP or analogues thereof to prevent or reduce bone fractures. Also disclosed are PTHrP or analogues thereof, such as abaloparatide, for increasing BMD and/or TBS in subjects in need thereof, as well as methods of using PTHrP or analogues thereof to increase BMD and/or TBS.